Insight Molecular Diagnostics (IMDX) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 4.99% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | 11.73% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 2.38% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 21.03% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 2.36% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 38.87% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -11.34% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 2.14% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 6.95% |
| 10 | Insight Molecular Diagnostics | 171.73 Mn | 142.80 Mn | 15,000.00 | 0.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | -29.01% |
| Jun 30, 2025 | -9.78% |
| Mar 31, 2025 | -17.10% |
| Dec 31, 2024 | -25.21% |
| Sep 30, 2024 | -22.95% |
| Jun 30, 2024 | -8.69% |
| Mar 31, 2024 | -6.49% |
| Dec 31, 2023 | -16.49% |
| Sep 30, 2023 | 3.79% |
| Jun 30, 2023 | 21.60% |
| Mar 31, 2023 | 27.20% |
| Dec 31, 2022 | 34.03% |
| Jun 30, 2022 | 180.21% |
| Mar 31, 2022 | 154.54% |
| Dec 31, 2021 | 140.37% |
| Sep 30, 2021 | 119.51% |
| Jun 30, 2021 | 92.63% |
| Mar 31, 2021 | 81.47% |